Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M107,541Revenue (TTM) $M36,852Net Margin (%)2.5Altman Z-Score1.4
Enterprise Value $M127,007EPS (TTM) $0.4Operating Margin %7.5Piotroski F-Score4
P/E(ttm)139Beneish M-Score-2.6Pre-tax Margin (%)4.7Higher ROA y-yN
Price/Book29.010-y EBITDA Growth Rate %0.3Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %-5.1Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow150y-y EBITDA Growth Rate %-73.8ROA % (ttm)1.1Higher Current Ratio y-yN
Dividend Yield %5.2PEG--ROE % (ttm)11.1Less Shares Outstanding y-yN
Payout Ratio %682Shares Outstanding M2,435ROIC % (ttm)7.7Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKHOTCHKIS & WILEY 2016-03-31 Reduce-0.52%$38.54 - $42.05
($39.84)
$ 44.1611%Reduce -26.34%8,915,323
GSKKahn Brothers 2016-03-31 Add0.36%$38.54 - $42.05
($39.84)
$ 44.1611%Add 55.97%131,950
GSKCharles Brandes 2016-03-31 Add0.1%$38.54 - $42.05
($39.84)
$ 44.1611%Add 3.98%4,474,409
GSKJohn Rogers 2016-03-31 Add0.05%$38.54 - $42.05
($39.84)
$ 44.1611%Add 7.17%1,582,913
GSKNWQ Managers 2016-03-31 Add0.02%$38.54 - $42.05
($39.84)
$ 44.1611%Add 6.02%498,115
GSKTweedy Browne 2016-03-31 Reduce-0.02%$38.54 - $42.05
($39.84)
$ 44.1611%Reduce -12.81%116,070
GSKKen Fisher 2016-03-31 Add0.01%$38.54 - $42.05
($39.84)
$ 44.1611%Add 1.09%11,657,855
GSKJoel Greenblatt 2016-03-31 Reduce$38.54 - $42.05
($39.84)
$ 44.1611%Reduce -1.24%51,331
GSKBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Add$38.54 - $42.05
($39.84)
$ 44.1611%Add 1.12%251,800
GSKDodge & Cox 2016-03-31 Reduce$38.54 - $42.05
($39.84)
$ 44.1611%Reduce -27.95%81,262
GSKCharles Brandes 2015-12-31 Reduce-0.21%$39.1 - $43.53
($40.81)
$ 44.168%Reduce -7.92%4,303,030
GSKKahn Brothers 2015-12-31 Add0.2%$39.1 - $43.53
($40.81)
$ 44.168%Add 47.13%84,600
GSKHOTCHKIS & WILEY 2015-12-31 Reduce-0.05%$39.1 - $43.53
($40.81)
$ 44.168%Reduce -2.40%12,102,919
GSKJohn Rogers 2015-12-31 Add0.01%$39.1 - $43.53
($40.81)
$ 44.168%Add 1.29%1,476,976
GSKKen Fisher 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 44.168%Add 0.03%11,531,673
GSKTweedy Browne 2015-12-31 Reduce$39.1 - $43.53
($40.81)
$ 44.168%Reduce -0.25%133,124
GSKNWQ Managers 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 44.168%Add 1.68%469,830
GSKDodge & Cox 2015-12-31 Reduce$39.1 - $43.53
($40.81)
$ 44.168%Reduce -44.42%112,782
GSKJoel Greenblatt 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 44.168%Add 1.01%51,973
GSKDodge & Cox 2015-09-30 Reduce-0.46%$37.56 - $45.14
($41.64)
$ 44.166%Reduce -98.37%202,915
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$22100.73view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14108.89view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29734.78view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12268view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14215.43view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12268view

Press Releases about GSK :

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    GlaxoSmithKline’s Sideways Dance May Pay Off in the Long Run Jul 22 2016 
    Why Berkshire Hathaway Dumped Johnson & Johnson Jul 19 2016 
    Andreas Halvorsen's Viking Global Gets Control of Stakes in 2 Companies for Backing Hot Biotech Jul 14 2016 
    Investing in Big Pharma: Pointers on Pfizer Jul 14 2016 
    Getting to Know VBI Vaccines Jul 13 2016 
    Jeff Auxier Sells Precision Castparts, AT&T, Microsoft Jun 23 2016 
    Steven Cohen Adds to Stake in Pernix Therapeutics Jun 07 2016 
    PhaseRX: The Latest Pick From a Legendary VC Firm May 24 2016 
    Kahn Brothers Adds to BP, GlaxoSmithKline Stakes May 10 2016 
    A Closer Look Into Veritas Pharma Apr 21 2016 

    More From Other Websites
    5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More Jul 26 2016
    Newly Acquired Products Boost GlaxoSmithKline’s Earnings Jul 26 2016
    GSK’s Novartis Acquisition Key to Growth in Its Vaccines Segment Jul 25 2016
    Director/PDMR Shareholding Jul 25 2016
    GSK 2Q16 Earnings: Did Pharmaceuticals Grow? Jul 25 2016
    Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise? Jul 25 2016
    Time to Sell Utilities, but Time to Buy 3 Other Great Dividends Jul 25 2016
    GlaxoSmithKline's Sideways Dance May Pay Off in the Long Run Jul 22 2016
    GlaxoSmithKline Segments That Drive Company’s Rising Revenues Jul 22 2016
    GSK’s HIV Products Expected to Have Driven 2Q Earnings Jul 22 2016
    BioFlash podcast: Why Big Pharma is hungry for bacteria Jul 22 2016
    Inside the Foreign Exchange Impact on Novartis’s Growth in 2Q16 Jul 21 2016
    How Did Novartis’s 2Q16 Earnings Stand up to Analyst Estimates? Jul 21 2016
    GSK ships 2016-17 seasonal influenza vaccines for US market Jul 20 2016
    VBIV: A Differentiated Immunology Company With Multiple Near Term Value Drivers Jul 20 2016
    Your inhaler's watching you: drugmakers race for smart devices Jul 20 2016
    Your inhaler's watching you: drugmakers race for smart devices Jul 20 2016
    Your inhaler's watching you: drugmakers race for smart devices Jul 20 2016
    Apple Goes After Enormous Medical Technology Market Jul 19 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)